Grant Street Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Grant Street Asset Management's BMY Position: Q2 2021 in Review
Grant Street Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 1,059 shares — an estimated $67K sold.
Grant Street Asset Management first reported a position in BMY in Q4 2020 and held it in 2 quarters. The position peaked at $67K in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Grant Street Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Grant Street Asset Management sold 1,059 Bristol-Myers Squibb shares in Q2 2021, an estimated $67K.
- Grant Street Asset Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 2 quarters.
- Grant Street Asset Management's Bristol-Myers Squibb position peaked at $67K in Q1 2021.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Grant Street Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.